KRYSKrystal Biotech, Inc.

$359.68

What is the market doing?

What the tape says about KRYS

Krystal Biotech, Inc. is +164% over the past year while the S&P 500 is +23%: 142 points ahead of the market.

+164%

1-year return · S&P 500 +23%

vs 200-day average
+31%

vs 200-day average · a clear uptrend

RSI (14)
72

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−1.7%

Below its 52-week high

2024-08-06$123.36 – $365.74 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$359.68
1 monthS&P 500 +3.7%
+9.7%
1 yearS&P 500 +23%
+164%
5 yearsS&P 500 +87%
+521%
vs 50-day average$332.58
+8.2%
52-week high
$365.74
52-week low
$137.46
Annualised volatility
43%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$5.0M
Calendar-year price return
YearReturn
2026 (year to date)+46%
2025+57%
2024+26%
2023+57%
2022+13%
2021+17%
2020+8.3%
2019+167%
2018+98%
Average return by calendar month, 2017–2026
MonthYearsPositiveAverage
Jan95 of 9+1.2%
Feb96 of 9+8.2%
Mar95 of 9+3.8%
Apr94 of 9−1.7%
May95 of 9+3.1%
Jun97 of 9+12%
Jul97 of 9+7.0%
Aug91 of 9−1.1%
Sep82 of 8−3.8%
Oct95 of 9+5.3%
Nov98 of 9+19%
Dec95 of 9−1.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.